Vaxcyte (PCVX): Officer sold ~$637K
Harpreet S. Dhaliwal, Officer at Vaxcyte, sold ~$637K of Vaxcyte shares.
- ~$637K
- Approx. value · 9,345 sh @ $68.16
- 69K
- Holds after · shares reported
- Traded
- Nov 11, 2026
- Filed
- Nov 13, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$128K)
- Oct 5, 2026Insider · 2 peopleInsiders: 2 sales (~$3.2M)
- Oct 6, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
- Nov 2, 2026Insider · 2 peopleInsiders: 4 sales (~$320K)
- Nov 4, 2026Company filing · Form 8-K · ResultsReported its results
- Nov 6, 20265% stakeT. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 9.6%
- Nov 6, 20265% stakeT. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 11.6%
- Nov 11, 2026 · this disclosureInsiderOfficer sold ~$637K of PCVX shares in the open market
What came next
- Nov 11, 2026Insider · 1 personInsiders: 2 sales (~$516K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Vaxcyte
For Vaxcyte, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 1 Congress trade report dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PCVX page.
Other recent filings by Harpreet S. Dhaliwal, Chief Technical Ops Officer
The full history of Harpreet S. Dhaliwal, Chief Technical Ops Officer is on the profile page.
How this filing works
Explore the data
Other disclosures at Vaxcyte
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 144Nov 12, 2026
- SEC Form 4Nov 4, 2026
- SEC Form 4Nov 4, 2026
- SEC Form 4Nov 4, 2026
Everything OQRO holds on this company is on its PCVX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
